Safety and Efficacy of Combined Therapy With Selinexor and Eribulin in Patients With Advanced Solid Tumors and TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Cancer 2023 Jul 15;129(14)2201-2213, BE Nelson, S Saleem, S Damodaran, N Somaiah, S Piha-Paul, JA Moore, B Yilmaz, D Ogbonna, DD Karp, E Dumbrava, AM Tsimberidou, DS Hong, J Rodon Ahnert, DR Milton, X Zheng, DJ Booser, NK Ibrahim, AP Conley, P Bhosale, CM Rojas Hernandez, D Tripathy, A Naing, F Meric-BernstamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.